Exact Mass: 439.0798

Exact Mass Matches: 439.0798

Found 107 metabolites which its exact mass value is equals to given mass value 439.0798, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

(2R)-2-Hydroxy-2-phenylethyl glucosinolate

{[(e)-(3-hydroxy-3-phenyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulphanyl}propylidene)amino]oxy}sulphonic acid

C15H21NO10S2 (439.0607)

(2S)-2-Hydroxy-2-phenylethyl glucosinolate is found in brassicas. (2S)-2-Hydroxy-2-phenylethyl glucosinolate is a constituent of Barbarea vulgaris (winter cress). Constituent of Barbarea vulgaris (winter cress). (2R)-2-Hydroxy-2-phenylethyl glucosinolate is found in brassicas.

Glucolimnanthin

1-S-[2-(3-methoxyphenyl)-N-(sulfooxy)ethanimidoyl]-1-thio-beta-D-glucopyranose

C15H21NO10S2 (439.0607)

An aralkylglucosinolic acid that consists of 1-thio-beta-D-glucopyranose attached to a (2-(3-methoxyphenyl)-N-(sulfooxy)ethanimidoyl group at the anomeric sulfur.

Glucoaubrietin

4-Methoxybenzyl glucosinolate

C15H21NO10S2 (439.0607)

N-Desmethyl-o-O-sulfate rosiglitazone

{2-[(2-{4-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]phenoxy}ethyl)amino]pyridin-3-yl}oxidanesulfonic acid

C17H17N3O7S2 (439.0508)

N-Desmethyl-o-O-sulfate rosiglitazone is a metabolite of rosiglitazone. Rosiglitazone is an antidiabetic drug in the thiazolidinedione class of drugs. It works as an insulin sensitizer, by binding to the PPAR receptors in fat cells and making the cells more responsive to insulin. It is marketed by the pharmaceutical company GlaxoSmithKline (GSK) as a stand-alone drug (Avandia) and in combination with metformin (Avandamet) or with glimepiride (Avandaryl). Annual sales peaked at approximately $2.5bn in 2006, but declined after reports of adverse effects. (Wikipedia)

N-Desmethyl-p-O-sulfate rosiglitazone

{6-[(2-{4-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]phenoxy}ethyl)amino]pyridin-3-yl}oxidanesulfonic acid

C17H17N3O7S2 (439.0508)

N-Desmethyl-p-O-sulfate rosiglitazone is a metabolite of rosiglitazone. Rosiglitazone is an antidiabetic drug in the thiazolidinedione class of drugs. It works as an insulin sensitizer, by binding to the PPAR receptors in fat cells and making the cells more responsive to insulin. It is marketed by the pharmaceutical company GlaxoSmithKline (GSK) as a stand-alone drug (Avandia) and in combination with metformin (Avandamet) or with glimepiride (Avandaryl). Annual sales peaked at approximately $2.5bn in 2006, but declined after reports of adverse effects. (Wikipedia)

Convergence

1-{pyrazolo[1,5-a]pyrimidine-3-carbonyl}-4-[4-(trifluoromethyl)benzenesulphonyl]piperazine

C18H16F3N5O3S (439.0926)

N-(3-Phenylpropyl)-3,4-dihydroxybenzylidene cyanoacetamide

2,2,4,4-tetracyano-N-{[3,4-dihydroxy-2-(3-phenylpropyl)phenyl]methylidene}-3-oxobutanamide

C24H17N5O4 (439.128)

D000970 - Antineoplastic Agents > D020032 - Tyrphostins

Althiomycin

C16H17N5O6S2 (439.062)

A peptide antibiotic isolated from soil and enteric bacteria. It is a protein synthesis inhibitor which exhibits antibacterial activity against both Gram-positive and Gram-negative bacteria.

2-Methoxybenzyl glucosinolate

C15H21NO10S2 (439.0607)

Glucolimnathin

3-Methoxybenzyl glucosinolate

C15H21NO10S2 (439.0607)

Annotation level-1 Acquisition and generation of the data is financially supported in part by CREST/JST.

3-Methoxy-dictamnine-4-(2,3,4-trimethoxy)-benzoic acid

"NCGC00160277-01!3-Methoxy-dictamnine-4-(2,3,4-trimethoxy)-benzoic acid"

C23H21NO8 (439.1267)

Cys Cys Asn Thr

(2S,3R)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-hydroxybutanoic acid